Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Fighting Fire with Fire: Virus Therapy as a Cancer Tr

<< Previous

Bullboard Posts

Next >>

Comment by Kswdeluxon Aug 23, 2021 11:51am

195 Views

Post# 33748500

RE:RE:Fighting Fire with Fire: Virus Therapy as a Cancer Tr

Well said

and

"BTW the trading SP, has little to do with future success."
especially biotech.

I am in total agreement.

the next 4-7 months are going to be very interesting to see what exactly unfolds.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market